FDA cleared the SEEG-Tx® System (STX-SYS-001) from Dixi Medical on Oct 29, 2026 under K260337, a traditional 510(k). The device falls under product code GXD, Generator, Lesion, Radiofrequency, regulated at 21 CFR 882.4400 as a Class 2 device. The review panel was Neurology.
FDA logged the submission as received on Feb 2, 2026. The decision came 269 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.
This is the only decision on file for Dixi Medical in the last 12 months of the tracker.